SAICO is a Vienna-based company founded in 2017 that focuses on the microfabrication of biosensors and lab-on-a-chip systems for biomedical applications. We facilitate the rapid translation of academic innovations into industrial production of diagnostic tools for personalized medicine.
Our core competence is the rapid and cost-efficient generation of functional prototypes needed to reduce the development time from initial idea to market-ready devices.
(1) advice on microfluidics-related issues
(2) on-site training in microfluidics handling; and
(3) customized technology solutions ranging from initial proof-of-concept studies to medium/large-scale engineering designs.
Prof. DI Dr. Peter Ertl
Dr. Rudolf Zinell
Johannes S. Brunner
SAICO provides in-depth microfluidics expertise, as well as access to our rapid prototyping technologies and patented technology platforms, including:
ADVISORY ON MICROFLUIDICS TECHNOLOGIES
Consulting including the establishment of microfluidic concepts, evaluation of and improvement microfluidic layouts; hands-on training in microfluidic handling; training in microfluidics fabrication; and workshops on microfluidics, cell chips, organ-on-a-chip technologies.
ORGAN-ON-A CHIP TECHNOLOGIES
Integration of complex biology in microfluidic devices and prototyping of customized 2D/3D cell culture systems including multilayered, membrane-based and sensor-integrated microfluidic devices; miniaturization of bioassay, biocompatibility studies and material-biology interaction analysis; and small scale production of microfluidic devices.
ESTABLISHMENT OF ON-CHIP DISEASE MODELS
In collaboration with our clinical partners we are currently working on the establishment of a rheumatic arthritis-on-a-chip, an osteoarthritis-on-a-chip and a Parkinson’s-on-a-chip platform.
SCREENING SERVICES BASED ON AUTOMATED MINIATURIZED CELL CULTURE SYSTEMS
Based on our proprietary membrane compression technology, we have established an automated microfluidic wound healing and cell migration assay for drug development and lead compound optimization studies or routine toxicological assessments.